These disparities in healthcare are a real challenge.

How many of you have lost a loved one due to gun violence that are here in this room? Raise your hand so I can see that.

We know that black children and teens are 14 times more likely than white children and teens to die because of gun violence.

This is a crisis. It demands a sense of urgency right now. We are raising the profile right now today, but we need action.

I just don't feel a sense of urgency here.

I understand, and we have heard from several media outlets, and I want to put some articles into the record that report that the White House is still planning to hold a listening session with several conservative think tanks and industry…

if we are unable to limit cigarette use to existing smokers that we should just ban it.

E-cigarettes are not approved by the FDA as a quit-smoking aid. So far, the research shows there is limited evidence that e-cigarettes are effective for helping smokers quit.

How many children are we going to allow to die before this is considered the emergency it is and we just say no?

I am so proud of this committee for leading the charge to finally allow for negotiation of prescription drug prices.

I thank the gentleman for leading this discussion about climate. What I really love about so many of our freshman Members, like Congressman Levin, is that they say how urgent the need is right now to act, a sense of urgency. I am on the…

Product hopping or evergreening is the reformulation of a drug by a brand-name manufacturer to delay competition and protect protection for profit.

Instead of truly innovating, drug manufacturers are taking advantage of the anticompetitive environment we have created.

We can't leave any stone unturned in examining ways to address this issue.

Competition is crucial to lowering prescription drug prices and improving America's access to lifesaving medication.

I feel that on this subcommittee where we have a very broad jurisdiction, we have been able to pass some important bills.

drug manufacturers are gaming the system to make more money at consumers' expense, and that has to stop.

My bill will allow for greater transparency in drug pricing.

If PBMs were doing such a good job on my behalf negotiating for Part D, for example, why am I paying so much more than those other countries?

But whatever the word or phrase, the bottom line is: drug manufacturers are gaming the system to make more money at consumers' expense.

I am proud to preside over this hearing in the Consumer Protection Subcommittee because Congress must take direct action to protect American consumers from the deceptive commercial actions that the drug manufacturers take to gouge…

So we owe it to the American people, and I will be doing everything I can in my power to do so.

It is clear from the testimony that we have heard today that Congress has an opportunity to act to combat the gaming tactics of Big Pharma.

The time I believe to act is now.

The legislation has a two-fold purpose. First, it will provide the Federal Trade Commission with authority to take action against a manufacturer engaged in product hopping.